Drugs / IN-114199
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06736912 | Dec 2024 → Aug 2025 overdue | constipation disorder | HK inno.N Corporation | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | IN-114199 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06736912 ↗ |
| Route | Oral | “single oral dose of IN-114199” NCT06736912 ↗ |